Korro Bio (KRRO) Earnings Date & Reports

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

KRRO is expected to report earnings to rise 18.33% to -35 cents per share on November 20

Q3'23

Est.

$-0.35

Q2'23

Beat

by $0.06

Q1'23

Missed

by $0.13

Q4'22

Beat

by $0.14

Q3'22

Beat

by $0.02

The last earnings report on August 10 showed earnings per share of -30 cents, beating the estimate of -36 cents. With 67.98K shares outstanding, the current market capitalization sits at 162.80M.

View a ticker or compare two or three

Compare

KRRO